Sunshine Pictures’s ₹282.14 crore initial public offering (IPO) entered its final day for public subscription today, August 20, 2026, with a price band of ₹342 to ₹360 per share. As of 10:35 A.M on the third day of bidding, the issue had been subscribed 24.59 times.
The basis of allotment is expected to be finalised on August 21, 2026, while the shares are tentatively scheduled to be listed on the NSE and BSE on August 25, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
18 August 2026 |
|
Subscription Closing Date |
20 August 2026 |
|
Basis of Allotment Date |
21 August 2026 |
|
Refund Initiation Date |
24 August 2026 |
|
Credit of Shares |
24 August 2026 |
|
Listing on BSE and NSE |
25 August 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[August 20, 2026, 10:35 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.18x |
|
Non-Institutional Investors (NIIs) |
53.16x |
|
Retail Individual Investors (RIIs) |
26.30x |
|
Total |
24.59x |
The company intends to utilise the net proceeds from the fresh issue towards:
Sunshine Pictures is engaged in the production, marketing and distribution of films, television serials and web series. Its notable projects include ‘Force’, ‘Force 2’, ‘Commando 2’ and ‘The Kerala Story’. The company follows a technology-driven, data-backed approach to content creation, using digital tools and audience analytics across production and post-production.
The company has produced 13 commercial films, two web series and three TV serials. It is currently working on projects including ‘Hisaab’ with Jio Studios, ‘Samuk’ and ‘Nanavati vs Nanavati’, scheduled for release in FY27. It has also recently launched two new verticals, Sunshine Music and Sunshine Write.
|
Particulars |
FY25 (in ₹ crore) |
FY24 (in ₹ crore) |
|
Revenue from operations |
103.33 |
133.79 |
|
EBITDA |
50.75 |
73.97 |
|
Profit After Tax (PAT) |
34.46 |
53.35 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here